CoronaCORONA CORPORATION5909東証スタンダード金属製品FY ending Mar 2026, consolidated, J-GAAP
Corona brought in ¥82B in revenue.
Out of every ¥100 of sales, about ¥2 is left as operating profit.
Revenue changed -3.9% from the prior year, operating profit -28.7%.
Revenue -3.9% · profit -28.7%, calculated from disclosed figures.
Operating leverage: 7.45× (profit growth ÷ revenue growth)
FY ending Mar 2023 → FY ending Mar 2024
FY ending Mar 2023 → FY ending Mar 2024
For every ¥100 Corona sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
EDINET (FSA Japan)
有価証券報告書-第78期(2025/04/01-2026/03/31)
EDINET (FSA Japan)
有価証券報告書-第77期(2024/04/01-2025/03/31)
EDINET (FSA Japan)
有価証券報告書-第76期(2023/04/01-2024/03/31)
EDINET (FSA Japan)
有価証券報告書-第75期(2022/04/01-2023/03/31)
EDINET (FSA Japan)
有価証券報告書-第74期(令和3年4月1日-令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書-第73期(令和2年4月1日-令和3年3月31日)
Extracted from XBRL: 49 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.